The 2019 Beyond Celiac Research Summit brought together stakeholders crucial to accomplishing the goal of developing new celiac disease treatments.

On November 15, Beyond Celiac held its 2nd research summit. The event, Getting over the Peak: The Final Ascent to Realizing Therapies in Celiac Disease, brought together:

• Clinician scientists
• Patients
• Entrepreneurial drug developers
• Patient advocacy leaders
• Private and public health care insurance
• Food and Drug Administration representatives

Several panel discussions were webcast about the challenges that our community faces in managing celiac disease, experiences that community members have had in participating in clinical trials, and barriers to research.

The 2019 Summit built on the results of our innovative 2015 summit, which was widely hailed as highly impactful and led to new scientific collaborations and sharpening of the focus of celiac disease physician-scientists.

This year’s summit took place against the backdrop of at least 12 clinical trials for celiac disease treatments. Our aim was to comprehensively address elements that must be in place to get a drug to market, including the remaining barriers in this decades-long journey to help patients with celiac disease.